Definitive Healthcare (NASDAQ:DH) Cut to Strong Sell at Zacks Research

Zacks Research cut shares of Definitive Healthcare (NASDAQ:DH) from a hold rating to a strong sell rating in a report issued on Thursday,Zacks.com reports.

DH has been the topic of several other reports. Barclays dropped their price target on Definitive Healthcare from $3.00 to $2.75 and set an “underweight” rating on the stock in a research report on Monday, December 8th. Wall Street Zen cut Definitive Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, February 28th. Canaccord Genuity Group dropped their target price on Definitive Healthcare from $4.00 to $3.00 and set a “hold” rating on the stock in a report on Friday, February 27th. Stephens reduced their price target on shares of Definitive Healthcare from $3.00 to $2.00 and set an “equal weight” rating for the company in a research report on Friday, February 27th. Finally, William Blair upgraded shares of Definitive Healthcare to a “strong-buy” rating in a report on Thursday, November 6th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, four have given a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average price target of $3.52.

Definitive Healthcare Trading Down 3.3%

NASDAQ DH opened at $1.18 on Thursday. The firm’s 50 day moving average price is $2.04 and its two-hundred day moving average price is $2.78. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.64 and a current ratio of 1.64. Definitive Healthcare has a twelve month low of $1.07 and a twelve month high of $4.70. The stock has a market cap of $166.80 million, a price-to-earnings ratio of -0.94 and a beta of 1.66.

Hedge Funds Weigh In On Definitive Healthcare

A number of hedge funds have recently added to or reduced their stakes in DH. Raymond James Financial Inc. bought a new position in Definitive Healthcare during the second quarter valued at approximately $32,000. State of Alaska Department of Revenue increased its position in Definitive Healthcare by 109.3% during the fourth quarter. State of Alaska Department of Revenue now owns 11,433 shares of the company’s stock worth $32,000 after buying an additional 5,970 shares during the last quarter. Savant Capital LLC bought a new position in Definitive Healthcare during the second quarter valued at about $45,000. Schonfeld Strategic Advisors LLC acquired a new stake in shares of Definitive Healthcare in the fourth quarter worth about $35,000. Finally, Los Angeles Capital Management LLC acquired a new stake in shares of Definitive Healthcare in the second quarter worth about $51,000. Institutional investors and hedge funds own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.